MAM
UTHR icon

Mizuho Asset Management’s United Therapeutics UTHR Stock Holding History

Mizuho Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$72K Hold
610
– – 0.02% 551
2016
Q2 		$65K Buy
+610
New +$68K 0.01% 632
2016
Q1 		– Sell
-610
Closed -$96K – 706
2015
Q4 		$96K Buy
610
+179
+42% +$26.1K 0.02% 532
2015
Q3 		$57K Hold
431
– – 0.01% 595
2015
Q2 		$75K Buy
+431
New +$77.5K 0.02% 522

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mizuho Asset Management's UTHR Position: Q3 2016 in Review

Mizuho Asset Management held its United Therapeutics (UTHR) position steady in Q3 2016 at 610 shares worth $72K. The position accounts for 0.02% of the portfolio, ranked #551.

Mizuho Asset Management first reported a position in UTHR in Q2 2015 and has held it in 5 quarters since. The position peaked at $96K in Q4 2015. 394 funds tracked by Wall St. Rank hold UTHR as of Q3 2016.

  • Mizuho Asset Management held 610 shares of United Therapeutics worth $72K as of Q3 2016.
  • Mizuho Asset Management left its United Therapeutics share count unchanged in Q3 2016.
  • United Therapeutics made up 0.02% of Mizuho Asset Management's portfolio in Q3 2016, its #551 holding.
  • Mizuho Asset Management first reported a position in United Therapeutics in Q2 2015 and has held it in 5 quarters since.
  • Mizuho Asset Management's United Therapeutics position peaked at $96K in Q4 2015.
  • 394 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.